CRON

Cronos Group
CRON

$2.14
0.92%

Market Cap: $818M

 

About: Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

Employees: 356

0
Funds holding %
of 6,686 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

38% more call options, than puts

Call options by funds: $14.3M | Put options by funds: $10.4M

24% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 37

1% more funds holding

Funds holding: 173 [Q1] → 175 (+2) [Q2]

9% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 23

0.28% less ownership

Funds ownership: 11.58% [Q1] → 11.3% (-0.28%) [Q2]

12% less capital invested

Capital invested by funds: $115M [Q1] → $101M (-$14M) [Q2]

100% less funds holding in top 10

Funds holding in top 10: 1 [Q1] → 0 (-1) [Q2]

Research analyst outlook

We haven’t received any recent analyst ratings for CRON.

Financial journalist opinion

Based on 10 articles about CRON published over the past 30 days